Cormorant Asset Management’s Tectonic Therapeutic TECX Stock Holding History
Bought
Maintained
Sold
Other funds holding TECX
CCM
GC
ACM
EMFAT
Cormorant Asset Management's TECX Position: Q1 2021 in Review
Cormorant Asset Management sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 20,336 shares — an estimated $3.4M sold.
Cormorant Asset Management first reported a position in TECX in Q2 2018 and held it in 11 quarters. The position peaked at $77.4M in Q3 2018. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.
- Cormorant Asset Management reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
- Cormorant Asset Management sold 20,336 Tectonic Therapeutic shares in Q1 2021, an estimated $3.4M.
- Cormorant Asset Management first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 11 quarters.
- Cormorant Asset Management's Tectonic Therapeutic position peaked at $77.4M in Q3 2018.
- 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.
Based on Cormorant Asset Management's 13F filing for Q1 2021, filed 17 May 2021.